Cargando…

The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population

The most common type of cardiovascular disease is coronary artery disease (CAD), in which a plaque builds up inside the coronary arteries that can lead to a complete blockage of blood flow to the heart, resulting in a heart attack. The CAD may be affected by various factors including age, gender, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Han Sung, Sung, Jung-Hoon, Ryu, Chang Soo, Lee, Jeong Yong, Ko, Eun Ju, Kim, In Jai, Kim, Nam Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711432/ https://www.ncbi.nlm.nih.gov/pubmed/33260749 http://dx.doi.org/10.3390/jpm10040257

Ejemplares similares

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort
por: Choi, Gun Ho, et al.
Publicado: (2023)

Study of the Association between VEGF Polymorphisms and the Risk of Coronary Artery Disease in Koreans
por: Ko, Eun-Ju, et al.
Publicado: (2022)

Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility
por: Oh, Jisu, et al.
Publicado: (2020)

Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women
por: Kim, Jung Oh, et al.
Publicado: (2016)

A study of associations between CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery disease
por: Park, Han Sung, et al.
Publicado: (2020)

Association of Thymidylate Synthase (TS) Gene Polymorphisms with Incidence and Prognosis of Coronary Artery Disease
por: Kim, Jung Oh, et al.
Publicado: (2023)

Association between HOTAIR lncRNA Polymorphisms and Coronary Artery Disease Susceptibility
por: Kim, In-Jai, et al.
Publicado: (2021)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Analysis of the Association Between MicroRNA Biogenesis Gene Polymorphisms and Venous Thromboembolism in Koreans
por: Ko, Eun Ju, et al.
Publicado: (2019)

Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary Adenocarcinoma
por: Lim, Ju Eun, et al.
Publicado: (2013)

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
por: Alotaibi, Fahad T., et al.
Publicado: (2019)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women
por: Ozgen, Merih, et al.
Publicado: (2012)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
por: White, Marquitta J., et al.
Publicado: (2015)

Predictive role of plasminogen-activator-inhibitor-1 (PAI-1) in non-ST-segment elevation acute coronary syndrome
por: Sinkovic, A, et al.
Publicado: (2002)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head
por: Kim, Hye- Ok, et al.
Publicado: (2011)

Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms Associated with Cardiovascular Risk Factors Involved in Cerebral Venous Sinus Thrombosis
por: Gogu, Anca Elena, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
por: Pierga, J. Y., et al.
Publicado: (1997)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Criteria and Search for Specific Assays for Active Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma
por: Kluft, C.
Publicado: (2000)

Gastric Expression of Plasminogen Activator Inhibitor (PAI)-1 Is Associated with Hyperphagia and Obesity in Mice
por: Kenny, Susan, et al.
Publicado: (2013)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
por: Lampelj, Maja, et al.
Publicado: (2015)

Increased expression of urokinase type plasminogen activator(u-PA), plasminogen activator inhibitor-1(PAI-1), and collagenases in Caco-2 cells infected by Salmonella typhimurium.
por: Park, C. G., et al.
Publicado: (1997)

Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic disease
por: Saffari, Babak, et al.
Publicado: (2012)

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix
Publicado: (1991)

Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice()
por: Gamble, Joanne, et al.
Publicado: (2013)

HMOX1 Gene Promoter Polymorphism is Not Associated with Coronary Artery Disease in Koreans
por: Han, Seong Woo, et al.
Publicado: (2014)

Fibronectin, Plasminogen Activator Inhibitor Type 1 (PAI-1) And Uterine Artery Doppler Velocimetry as Markers of Preeclampsia
por: Bodova, Kristina Biskupska, et al.
Publicado: (2011)

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
por: Mennesson, Marie, et al.
Publicado: (2023)

PSUN171 CORRELATIONS BETWEEN SERUM AND TEAR PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE PLASMINOGEN ACTIVATOR (tPA) IN PATIENTS WITH DIABETIC RETINOPATHY
por: Jasmiad, Nurbadriah, et al.
Publicado: (2022)

Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells
por: Roy, Ananya, et al.
Publicado: (2015)

Association of Polymorphisms in FSHR, INHA, ESR1, and BMP15 with Recurrent Implantation Failure
por: Ko, Eun-Ju, et al.
Publicado: (2023)

Association Study between Mucin 4 (MUC4) Polymorphisms and Idiopathic Recurrent Pregnancy Loss in a Korean Population
por: Kim, Ji-Hyang, et al.
Publicado: (2022)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
por: Song, J., et al.
Publicado: (2000)

Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_nfsbutdugk854tjfjhct3a4v97